Egypt’s Arab Drug for Pharmaceuticals and Chemical Industries H2 net profit ups to 18bn pounds

Egypt’s state-owned Arab Drug Company for Pharmaceuticals and Chemical Industries (ADCO) unveiled Thursday that its net profit jumped to 18.3 million Egyptian pounds ($1 million) during the six months ended in December 2017.

Earlier, net profit stood at 10.2 million pounds during the six months ended in December 2016.

Established in 1963, ADCO is an Egyptian joint venture company, which has a long history of achievements since its foundation. It is one of the leading firms in pharmaceutical drug manufacturing in Egypt and the Arab world.